Splicing Reporter Mice Revealed the Evolutionally Conserved Switching Mechanism of Tissue-Specific Alternative Exon Selection by Takeuchi, Akihide et al.
Splicing Reporter Mice Revealed the Evolutionally







1Department of Functional Genomics, Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan, 2Laboratory of Gene Expression, School
of Biomedical Science, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan, 3Department of Anatomy and Developmental Biology, Kyoto University Graduate
School of Medicine, Sakyo-ku, Kyoto, Japan
Abstract
Since alternative splicing of pre-mRNAs is essential for generating tissue-specific diversity in proteome, elucidating its
regulatory mechanism is indispensable to understand developmental process or tissue-specific functions. We have been
focusing on tissue-specific regulation of mutually exclusive selection of alternative exons because this implies the typical
molecular mechanism of alternative splicing regulation and also can be good examples to elicit general rule of ‘‘splice
code’’. So far, mutually exclusive splicing regulation has been explained by the outcome from the balance of multiple
regulators that enhance or repress either of alternative exons discretely. However, this ‘‘balance’’ model is open to questions
of how to ensure the selection of only one appropriate exon out of several candidates and how to switch them. To answer
these questions, we generated an original bichromatic fluorescent splicing reporter system for mammals using fibroblast
growth factor-receptor 2 (FGFR2) gene as model. By using this splicing reporter, we demonstrated that FGFR2 gene is
regulated by the ‘‘switch-like’’ mechanism, in which key regulators modify the ordered splice-site recognition of two
mutually exclusive exons, eventually ensure single exon selection and their distinct switching. Also this finding elucidated
the evolutionally conserved ‘‘splice code,’’ in which combination of tissue-specific and broadly expressed RNA binding
proteins regulate alternative splicing of specific gene in a tissue-specific manner. These findings provide the significant cue
to understand how a number of spliced genes are regulated in various tissue-specific manners by a limited number of
regulators, eventually to understand developmental process or tissue-specific functions.
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Introduction
Genome projects have shown that metazoans generate a hugely
diverse proteome from a limited number of genes. This finding
underscores the importance of alternative splicing, through which
a single gene can generate multiple structurally and functionally
distinct protein isoforms. Moreover, recent transcriptome analyses
with splicing-sensitive microarrays or deep sequencers have
revealed that alternative splicing occurs in more than 90% of
multi-exon genes in human [1] and over 60% of these cases are
regulated in a tissue- and cell type-specific manner [2]. Alternative
splicing is regulated by auxiliary cis-elements with regulatory
proteins that enhance or repress splicing of adjacent exons [3,4]
however, the mechanism by which a number of genes are
regulated in various tissue-specific manner by a limited number of
regulatory factors remains unclear.
In mammals, fibroblast growth factor-receptor 2 (FGFR2) is one
of the best characterized gene in which mutually exclusive
alternative splicing produces two isoforms. Exon 8 (also termed
IIIb) isoform is specifically expressed in epithelial tissues, whereas
exon 9 (or IIIc) isoform is selected in non-epithelial or
mesenchymal tissues [5,6]. The structural difference between
two splice isoforms markedly affects the specificity of ligand–
receptor binding [7,8,9], and exon switching is shown to be
essential for development in the mouse [10,11]. Several factors
have been identified which positively or negatively regulate either
of alternative exons of FGFR2 independently. For exon 8
regulation, Del Gatto-Konczak et al. found that heterogeneous
nuclear ribonucleoprotein, hnRNP A1, binds to exon 8 (also
termed K-SAM exon) as ESS (exonic splicing silencer) and
represses its inclusion [12]. Carstens et al. found the polypyr-
imidine tract binding protein (PTB) represses exon 8 inclusion
through ISS-1 and ISS-2 (intronic splicing silencers-1 and 2) [13].
Warzecha et al. recently cloned RBM35a and RBM35b as
epithelia-specific activators of exon 8 inclusion, and renamed them
epithelial splicing regulatory proteins 1 and 2 (ESRP1 and
ESPR2), respectively [14]. For exon 9 regualtion, Chen et al.
found that Tra2b represses the selection of exon 9 [15]. Baraniak
et al. reported that Fox2 represses selection of exon 9 through
binding to a UGCAUG sequence in intron 8 [16]. Hovhannisyan
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inclusion of exon 9 [17]. Mauger et al. showed that hnRNP H and
F interact with Fox2 and repress exon 9 inclusion [18]. Also,
presence of unknown enhancer is speculated for exon 9 inclusion
through ISE (intronic splicing enhancer) in intron 9 [14]. So far,
mutually exclusive splicing regulation is widely believed as the
outcome from the balance of multiple regulators that enhance or
repress either of alternative exons discretely [19,20]. However, this
‘‘balance’’ model is open to questions, 1) How the balance of
multiple regulators can ensures the selection of only one
appropriate exon out of several candidates? 2) Whether transcrip-
tional or post-transcriptional control of multiple regulators is
possible to achieve distinct switching of alternative exons? 3) If 2) is
the case, how to control the multiple regulators at once for exon
switching? To answer these questions, we generated a bichromatic
fluorescent splicing reporter system for mammals using FGFR2
gene as a model. This reporter contains entire cis-elements
necessary to reproduce native alternative splicing regulation and
enable us to visualize and monitor it in vitro and in vivo. The
transgenic mice expressing this splicing reporter clearly showed the
epithelial tissue-specific splicing pattern throughout their entire
bodies. By using this splicing reporter, we demonstrate that key
regulators define the single exon expression in the tissue-
dependent manner through the ordered splice-site recognition of
the mutually exclusive exons.
Results
Generation of the FGFR2 splicing reporter system
We used a 3.7-kb genomic fragment of FGFR2 gene that included
two alternative exons (exon 8 and 9) flanked by their upstream and
downstream exons (exon 7 and 10), with introns in between
(Figure1A).Byusingmostlyentiregenomicregionaroundalternative
exons, this reporter system was expected to contain all the regulatory
cis-elements essential for tissue-specific regulation and to tell which
splice site sequences and cis-elements are truly critical for regulations.
The genomic fragment was cloned into a vector containing RFP and
EGFP in tandem with different reading frames [21]. With this
reporter system, splicing regulation could be monitored from a single
reporter vector that expresses either EGFP when exon 8 is chosen or
RFP when exon 9 is selected (Figure 1A).
By using two prostate carcinoma cell lines, AT-3 and DT-3
cells, we then examined whether the reporter system could reflect
cell type-specific splicing regulation. AT-3 cell is a mesenchymal-
type cell that specifically expresses exon 9 isoform of endogenous
FGFR2, and DT-3 cell is an epithelial-type cell that predomi-
nantly expresses exon 8 isoform [22]. When this reporter system
was introduced into these two cell lines, AT-3 cell specifically
expressed exon 9-RFP and DT-3 cell predominantly expressed
exon 8-EGFP (Figure 1B). We therefore could confirm that our
reporter vector reflects cell type-specific regulation of endogenous
FGFR2 splicing.
We next checked whether our reporter system could show tissue-
specific regulation of FGFR2 splicing in vivo by generating
transgenic mice from this reporter. A well-known change in the
FGFR2 splicing isoforms occurs in mouse development stages from
E14.5 to E16.5. In these stages, differentiation of future epithelial
cells is induced and they start expressing exon 8 isoform of FGFR2
to receive morphogen signals, such as FGF-10, from mesenchymal
cells [23]. When the whole body of a transgenic embryo was
examinedatE14.5,abroadRFPsignalwasdetectedthroughoutthe
entire body, and a specific EGFP signal was detected as the whisker
pattern and on the edges of limbs or the body (Figure 1C). We
further evaluated the detailed expression profile through examining
series of sections from the transgenic embryos in the late
development stage of E16.5 (Figure 1D). An EGFP signal was
detected specifically in cells on the surface of the skin and bulbs of
hair follicles, where differentiated epithelial cells were located
(Figure 1D, shown witharrows). Also, the EGFP signal was detected
at epithelial cells in the alveoli of the lung, in the esophagus and
colon, at the thymus epithelia, and at the salivary gland ductal cells
(Figure 1D, arrows in the top and middle panels). A strong RFP
signal was detected in the developing brain (hippocampus) and
peripheralnervous system (trigeminal ganglia) (Figure 1D,arrows in
bottom panels). Expression patterns of EGFP were compatible with
reported FGFR2 exon 8 expression patterns [23,24], indicating that
our reporter system reflects endogenous splicing regulation of
FGFR2 in vivo and the genomic fragment used in the vector
contains the regulatory elements necessary for tissue-specific
switching of mutually exclusive exons.
Unbalanced sequence of 39 splice site is essential for
mutually exclusive exon selection
In the embryos of splicing reporter transgenic mouse, RFP was
expressed almost throughout the entire body, and EGFP was
specifically expressed in epithelial cells. This expression pattern
suggested the possible regulatory mechanism that exon 9 was
dominantly selected as ‘‘default’’ in reporter transgenic mouse, and
epithelial-specific regulators might promote inclusion of exon 8. To
test this hypothesis, we initially compared sequence of alternative
exons including their 39 and 59 splice sites. The major difference
identified between these two exons is that exon 8 has a weaker 3’
splice site and a polypyrimidine moiety that contains several
mismatches from the consensus sequence (Figure 2A, TGTTCTAG
c a ) ,w h e r e a se x o n9h a ss t r o n g e r3 ’s p l i c es i t ew h i c hh a sc o n s e r v e d
consensus sequences (Figure 2A, TTTTCTAG gc). There are no
obvious differences in their 5’ splice sites (data not shown). To
examine whether the unbalanced 3’ splice site is essential for
‘‘default’’ selection of exon 9 in non-epithelial cells, we introduced
mutations in their 3’ splice sites and observed change in splicing
regulations. We prepared two types of mutated vectors, one has the
same stronger 3’ splice sites on both exon 8 and 9 (Figure 2A, E8-S
vector), and the other has the same weaker 3’ splicesites on both exon
8 and 9 (Figure2A, E9-W vector). These vectors were transfected into
AT-3 and DT-3 cells, and the change of splicing regulation was
examined by RT-PCR. When WT vector was introduced into AT-3
cell, it adopted almost 100% of the exon 9 form, whereas DT-3 cell
adopted around 45% {34.5/(34.5+42.7)%} of exon 8 form among
the single inclusion product (Figure 2B, lane 1, 4), which was
consistent with the expression pattern of fluorescence in Figure 1B.
Our splicing reporter was designed not to cause early premature
termination codon in double-inclusion form to escape the nonsense-
mediated decay (NMD) reaction [25]. Wetherefore could monitor all
splicing products, including the double-inclusion and the double-skip
forms. Strikingly, when E8-S vectors were transfected, AT-3 cell
mostly expressed the double-inclusion form, meaning that two
alternative exons were processed as constitutive exons (Figure 2B,
lane 2). This result indicates that the weaker 39 splice site of exon 8 is
critical for single exon selection of exon 9 from two mutuallyexclusive
exons in non-epithelial AT-3 cell (Figure 2B, lane 2), though the ESS
or ISS on or close to exon 8 may be required for the complete
suppression [13,26,27]. When the 3’ splice site of exon 9 was
weakened (E9-W vector), selection in DT-3 cell almost fully switched
to exon 8 (Figure 2B, lane 4 and 6), indicating that full repression of
exon 9 might be important for exon 8 inclusion in epithelial DT-3
cell. Thus unbalanced 3’ splice sites are essential for the single exon
choice from mutually exclusive exons and for their switching.
The Knight’s Fork Regulation
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Results in Figure 2 showed that weaker 3’ splice sites of exon 8 is
essential for the single exon selection of exon 9 in non-epithelial
AT-3 cell. And epithelial DT-3 cell efficiently chose exon 8 form
when 39 splice site of exon 9 was weakened. These observations
suggest a possibility that repression of exon 9 causes switching to
exon 8. To examine this hypothesis, we introduced mutations on
either or both of the 3’ and 5’ splice sites of exon 9 to destroy its
splice site consensus sequence mimicking repression, and trans-
fected these into AT-3 cell (Figure 3A). When both splice sites of
exon 9 were mutated (Figure 3A, 39&59 ss Mut), AT-3 cell
expressed the exon 8 form (22.9%) and the double-skip form
(77.1%) (Figure 3B, lane 4). These results indicated that blocking
of exon 9, at least partially, promotes switching to exon 8 in AT-3
cell. Interestingly, mutation of the 3’ splice site (Figure 3A, 39 ss
Mut) was just sufficient to cause this switching (Figure 3B, lane 2),
whereas mutation of the 5’ splice site (Figure 3A, 59 ss Mut)
produced an aberrant splicing product of exon 9 using a cryptic 5’
splice site at ggGT in exon 9 (Figure 3B, lane 3 indicated by
arrowhead and scheme was illustrated on the right side). These
results indicate that recognition of 39 splice site is essential for exon
9 selection, suggesting the possibility that recognition of exon 9 is
its 39 splice site dependent. To test this hypothesis, we performed
in vitro splicing assay to directly monitor the splice site recognition
by U2 and U1 snRNA/snRNP binding (Figure 3C). The
32P-
labeled RNA probes for wild-type and mutated exon 9 containing
the flanking introns (top panels of Figure 3C) were crosslinked by
UV irradiation after incubation with HeLa nuclear extract and
separated by electrophoresis. HeLa cell was confirmed to have
non-epithelial cell character. The specificity of U2 or U1 binding
was confirmed by addition of an oligonucleotide complementary
to U2 or U1, and RNase H digestion [28,29] (Figure 3C and
Figure S1). In the splicing conditions, binding and shift of U1 and
U2 snRNAs were observed with the WT RNA probe, in which the
U1 and U2 bands overlap (Figure 3C, lane 1–4, and Figure S1,
lane 1–4, indicated by an arrow). They became fainter by RNase
H digestion with U1 (Figure 3C, lane 3, and Figure S1, lane 3) or
U2 oligos (Figure 3C, lane 4, and Figure S1, lane 4). Shifted band
almost disappeared with double digestion with U1+U2 oligos
(Figure S1, lane 7), while the band was resistant against the RNase
H digestion with U6 oligo (Figure S1, lane 8), indicating that the
exon 9 RNA probe is recognized by U1 and U2 oligos in this
splicing condition. Strikingly, the 3’ splice site mutation of the
exon 9 RNA probe resulted in a significant loss of the shifted band
(Figure 3C, lane 6–8). These results suggested that recognition of
exon 9 primary depends on the binding of U2 snRNA to the 3’
splice site. On the contrary, with the probe harboring with 5’ splice
site mutation (5’ ss mutation), binding of both U1 and U2 was
retained (Figure 3C, lane 10–12), in good accordance with the
results of RT-PCR shown in Figure 3B, lane 3. These results
suggest a possibility that binding of U2 snRNA supports the
binding of U1 snRNA, so that much weaker cryptic 5’ splice sites
in exon 9 was used in its 59 ss mutation (Figure 3B, lane 3 and
Figure 3C, lane 12 indicated by an arrowhead with an asterisk).
These observations give a possible explanation why the selective
use of exon 9 in non-epithelial cells depends on the relative
strength of its 3’ splice site.
Identification of silencing elements for exon 9
recognition
Non-Epithelial or Mesenchymal regulation, unbalanced 3’
splice sites are essential for single exon selection of exon 9 in
non-epithelial cells and recognition of exon 9 is its 39 splice site
dependent. Also disruption of this 3’ splice site of exon 9 partially
caused switching to exon 8. These results suggest the presence of
silencer(s) for exon 9 to cause switching to exon 8 in epithelial cell.
To test this hypothesis, we initially screened suppressive cis-
elements located near the 3’ splice site of exon 9, and picked up
two highly conserved sequences: the UGCAUG sequence and
ISE/ISS-3 (intronic splicing enhancer/silencer-3) in intron 8, both
of which have been reported as the silencing cis-elements for exon
9 [16,30] (Figure 4A). To examine whether these two cis-elements
are essential for silencing exon 9, we introduced mutations in
either or both UGCAUG and ISE/ISS-3 in our reporter, and
transfected into epithelial DT-3 cell. First, we substituted
UGCAUGCAUG for UACGUACGUG to disrupt the binding
to the RNA-binding protein of Fox, which was reported as the
repressor of exon 9 [16]. Then, the ratio of exon 8 selection in DT-
3 cell fell by a half (44.7% to 21.9%, Figure 4B, lane 2). Next, we
deleted ISE/ISS-3, an 85-bp sequence containing several
dinucleotide GU sequences. The deletion of ISE/ISS-3 reduced
the ratio of exon 8 inclusion to one-fourth (44.7% to 12.4%,
Figure 4B, lane 3). When both of these elements were mutated,
DT-3 cell could no longer choose exon 8, and all splicing products
were the exon 9 form (Figure 4B, lane 4). These results indicate
that DT-3 cell use both of these cis-elements to select exon 8
presumably by silencing the exon 9 via its 3’ splice site.
Regulatory mechanism of transacting factors to switch
exons
Results from Figure 4 suggest that both UGCAUG and ISE/
ISS-3 are necessary and sufficient for selecting exon 8. A previous
study has shown that Fox2 promotes exon 8 inclusion through
UGCAUG in intron 8 [16]. Also, a recent study from cDNA
library screening identified epithelial splicing regulatory protein
ESRP1 and ESRP2, which mediate exon 8 inclusion through
binding to ISE/ISS-3 [14]. We therefore examined whether Fox1,
Fox2, ESRP1, and ESRP2 promote switching from exon 9 to exon
8. First, we examined and compared the expression levels of these
RNA-binding proteins between AT-3 and DT-3 cells by RT-PCR.
Fox2 was expressed in both cell lines at similar levels, whereas
expression of Fox1 was undetectable (Figure 4C), and both ESRP1
and ESRP2 were specifically expressed in epithelial type DT-3 cell
(Figure 4C). Considering the observation that both UGCAUG and
Figure 1. Construction of FGFR2 splicing reporter vector and their expression patterns. (A) Scheme of FGFR2 splicing reporter vector. The
genomic fragment of mouse FGFR2 including exon 7 through 10 was amplified and introduced into the reporter vector containing a CAGGS
promoter and RFP-EGFP with different reading frames. Modified glutathione-S-transferase gene (indicated as ‘‘G’’) was inserted in front of the exon7
in-frame. A schematic representation of the mRNA derived from the reporter under the alternative splicing regulation is also shown; the numbers
indicate the reading frames. (B) Expression pattern of splicing reporter in vitro. The reporter vector was introduced into two rat prostate cancer cell
lines AT-3 and DT-3, which have different cell-type specificities. Scale=200 mm. (C) Expression pattern of splicing reporter in vivo. Fluorescence
images of transgenic reporter mouse embryos at E14.5. Tg(+) is an embryo carrying the reporter vector, and Tg(–) is one of its litter-mate lacking the
vector. Arrowheads in Tg(+) indicate EGFP signals with the patterns of whiskers (upper arrowhead) and the edge of a limb (lower arrowhead), both of
which are magnified and indicated by white rectangles in the upper left-hand and lower right-hand corners, respectively (scale=1 mm). (D) Sections
from transgenic reporter mouse embryos at E16.5. Each panel shows sections from the indicated tissues, the upper one from Tg(+) and the lower
from Tg(–). Portions expressing the EGFP signal are indicated by white arrows (scale=100 mm).
doi:10.1371/journal.pone.0010946.g001
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(Figure 4B), broadly expressed Fox2 might cooperates with
epithelial-specific ESRP1 and ESRP2 for exon 8 inclusion. To
test this hypothesis, we transfected our FGFR2 splicing reporter
with Fox1, Fox2, ESRP1, or ESRP2, or combinations of these
into HeLa cell, which has non-epithelial cell character (Figure 5A,
lane 1).
When Fox1 or Fox2 was introduced into HeLa cell, selection of
exon 8 increased in a dose-depend manner and reached 10%
(Figure 5A, lanes 2–4) or 40% (Figure 5A, lanes 5–7), respectively.
Figure 2. Unbalanced sequence of 39 splice sites is essential for mutually exclusive exon selection. (A) Scheme for 3’ splice site mutation
on exons 8 and 9. Uppercase letter is intron and lowercase is exon sequence. Red characters indicate mismatches from the conserved consensus
sequence in the 3’ splice site and poly-pyrimidine moiety, and underline indicate mutated sequence. The yellow arrows with ‘‘primer’’ represent the
positions amplified in RT-PCR. (B) RT-PCR from AT-3 and DT-3 cells transfected the indicated vectors. Splice products were digested with EcoRV, which
uniquely cuts the PCR product containing exon 9. Each band was identified and indicated with the scheme of splice products. Arrowheads indicate
nonspecific PCR products, which was confirmed by sequencing. The asterisk indicates the splice product came from double inclusion of exon 8 and
exon 9. The bar graph shows the amount of each splicing product, and is based on calculations from three independent experiments; the mean value
for each splice product is show in the respective column with an error bar showing the SD (standard error).
doi:10.1371/journal.pone.0010946.g002
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increased in a dose-depend manner, and reached over 90%
(Figure 5A, lanes 8–10 and 15–17, respectively). As HeLa cell
expresses endogenous Fox2 in a similar manner to AT-3 cell
(Figure 5A, lane 1), we introduced ESRP1 or ESRP2 under the
Fox2 knockdown condition, and evaluated the cooperative effects
of ESRP1 or ESRP2 with endogenous Fox2. The knockdown
efficiency of Fox2 was more than 80% at the mRNA level (average
81.2%). Knockdown of endogenous Fox2 decreased the ratio of
exon 8 selection promoted by ESRP1 or ESRP2, with a maximum
reduction of 24% (35.1–11.0% Figure 5A, lane 8 versus lane 11) or
23% (55.9–32.6%, lane 15 versus lane 18), respectively. When
both Fox2 and ESRP1 were transfected, the ratios of exon 8
inclusion were similar to those obtained with a single transfection
of ESRP1 (Figure 5A, lanes 21–24). These results indicate that
introduced ESRPs promote exon 8 inclusion with endogenous
Fox2, suggesting that Fox2 and ESRPs cooperatively act together
for exon 8 inclusion. These results were also confirmed by means
of the fluorescence from the splicing reporter co-transfected with
Fox1, Fox2, ESRP1, or ESRP2, or both Fox2 and ESRP1
(Figure 5B). Over-expression of ESRP1 or ESRP2 changed the
color from red to green, but Fox1 or Fox2 alone had a smaller
effect on the color change. Co-transfection of Fox2 and ESRP1
gave the maximum effect on the color switching which reflected
Figure 3. Promoted selection of exon 8 by disruption of 39 splice site of exon 9. (A) Scheme of 3’ and 5’ splice site mutation on exon 9.
Uppercase letter is intron and lowercase is exon sequence, red characters indicates mutated sequence. (B) RT-PCR from AT-3 cells into which the
indicated vectors were introduced. Arrowshead indicate aberrant spliced product that used the 5’ cryptic splice site inside exon 9. The bar graph,
which represents the amount of each splicing product, is based on calculations from three independent experiments; the mean value for each splice
product is show in the respective column with an error bar showing the SD (standard error). (C) Results of the in vitro splice site recognition assay.
The scheme for exon 9 shows the position of the splice site mutation as ‘‘x’’. ‘‘X-link’’ shows the presence or absence of UV-induced crosslinks in
samples after the in vitro splicing reaction. ‘‘U1 oligo’’ and ‘‘U2 oligo’’ represent the digestion of RNA samples by RNaseH with complementary oligos
for U1 or U2. The band shown by arrowheads with asterisk may be a probe crosslinked with U1 that binds to the cryptic 5’ splice site inside exon 9,
because it was detected in the 5’ ss mutated probe and digested with U1 oligo.
doi:10.1371/journal.pone.0010946.g003
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We then tested whether exon switching by Fox2 and ESRP1
depends on UGCAUG and ISE/ISS-3 in intron 8.
We performed overexpression study of Fox2 and/or ESRP1 on
reporter vectors mutated on either UGCAUG, ISE/ISS-3, or both
of them with or without knock down condition of endogenous
Fox2. When Fox2 was transfected with the UGCAUG site-
mutated reporter, the promoting effect of Fox2 on exon 8
inclusion was lost (Figure 6A, lane 7). Overexpression of ESRP1
still promoted exon switching of the UGCAUG-mutated reporter,
but the ratio of exon 8 selection was slightly reduced (Figure 6A,
lane 8) in comparison with the wild-type reporter (Figure 6A, lane
3). To the contrary, when ISE/ISS-3 was mutated, the promotion
effect of ESRP1 on the exon switching was significantly reduced
(Figure 6A, lanes 13), and the effect of Fox2 remained (Figure 6A,
lanes 12 and 15). When both UGCAUG and ISE/ISS-3 were
mutated, neither Fox2 nor ESRP1 caused a drastic switching any
more (Figure 6A, lane 16–20). These results showed that Fox and
ESRP cooperatively promote switching from exon 8 to 9 through
the cis-elements of UGCAUG and ISE/ISS-3 located near exon 9.
Next, we tested whether Fox and/or ESRP cause switching
from exon 9 to exon 8 through interruption of exon 9
recognition. We examined this under the in vitro splicing
conditions using
32P-labeled RNA probe of exon 9 with introns
containing UGCAUG and ISE/ISS-3 sites (Figure 6B, top panel)
and the exon 8 RNA probe of same stretches. When the exon 9
probe was crosslinked by UV irradiation after incubation with
HeLa nuclear extract and separated by electrophoresis, shifted
band by closslinking U1 and U2 was observed as overlap
(Figure 6B, lane 2, indicated by arrow), as same as Figure 3C.
However, in the exon 8 probe, only shifted band by U1 was
observed (Figure 6B, lane 8, indicated by arrow, and data not
shown for RNaseH digestion), presumably due to its weaker 39
splice site. When recombinant Fox2 or ESRP1 protein was added
with the exon 9 probe, shifted binds by U1 and U2 snRNA were
decreased (Figure 6B, lanes 4 and 5, respectively), and almost
disappeared by addition of both Fox2 and ESRP1 proteins
(Figure 6B, lane 6). However, suppressive or activating effect of
Fox2 or/and ESRP1 was not obvious with exon 8 probe
(Figure 6B, lanes 9–12). These data indicate that both Fox and
ESRP interrupt exon 9 recognition in vitro. Combining results
from Figure 5 and Figure 6 indicate that Fox and ESRP disrupt
exon 9 recognition from its 39 splice site through UGCAUG and
ISE/ISS-3, and promoted switching to exon 8.
Figure 4. Identification of silencing elements for exon 9 recognition. (A) Scheme of cis-mutation experiment on UGCAUG and ISE/ISS-3
which is located upstream of exon 9. Red characters indicated mutated sequences or deletions. (B) RT-PCR from AT-3 cell into which the indicated
vectors were introduced. The bar graph shows the amount of each splicing product, and is based on calculations from three independent
experiments; the mean value for each splice product is show in the respective column, with an error bar showing the SD (standard error). (C) RT-PCR
from AT-3 and DT-3 cells showing amplified endogenous FGFR2, Fox1, Fox2, ESRP1, and ESRP2. The arrowhead in ESRP1 corresponds to two splice
isoforms which was confirmed by sequencing.
doi:10.1371/journal.pone.0010946.g004
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In vitro study showed that disruption of exon 9 recognition from its
39 splice site by Fox and ESRP through UGCAUG and ISE/ISS-3
promoted switching to exon 8. Remaining question is whether the
expression of Fox and ESRP coincides with the expression of exon 8
form in tissue-specific manner during development in vivo. We
examined the expression profiles of Fox1, Fox2, ESRP1, and ESRP2
by in situ hybridization using the serial sections from our reporter
transgenic mice embryos at E16.5 (Figure 7). As we have already
shown in Figure 1D, the exon 8-EGFP expression was on left panels
(as indicated by white arrows). In the in situ hybridization performed
with adjacent sections, Fox1 expression was not detected in tissues
where the EGFP signal was observed, whereas strong signal of Fox1
was detected mainly in neuronal tissues in the same sections (data not
shown). To the contrary, Fox2 mRNA was detected broadly
throughout whole embryos at this stage, and its expression was
overlapped with exon 8-EGFP signals localized in the epithelial
tissues (indicated by black arrows). The expression of ESRP1 and
ESRP2 was specifically detected in epithelial tissues (indicated by
black arrows) and these expression almost completely overlapped
with exon 8-EGFP signals during developing stage. These observa-
tions in vivo support an epithelial regulation model in Figure 8A in
which tissue specific factor ESRPs act together with generally
expressed Fox family to promote exon 8 inclusion.
Discussion
Several groups have generated reporter system to visualize
splicing regulation of FGFR2 gene. Newman et al. generated
fluorescent reporter vectors with the minimum genomic region
that can reflect endogenous splicing regulation in AT-3 and DT-3
Figure 5. Foxs and ESRPs promote switching from exon 9 to exon 8. (A)RT-PCR from HeLa cell transfected the wild-type reporter and
indicated cDNA expression vectors with or without Fox2 siRNA. The bar graph shows the amount of each splicing product. (B) Fluorescent
microscopy image of HeLa cell transfected the wild-type reporter with indicated cDNA expression vectors (scale bar=200 mm).
doi:10.1371/journal.pone.0010946.g005
The Knight’s Fork Regulation
PLoS ONE | www.plosone.org 8 June 2010 | Volume 5 | Issue 6 | e10946cells. With this reporter, they identified specific ISEs, including
ISS/ISS-3, that respond to Fox regulation [31]. Bonano et al.
constructed another fluorescent reporter vector by using the
genomic fragment around exon 8, and they visualized the
regulation of exon 8 inclusion in the mouse [32]. In this study,
we originally developed a transgenic reporter system using FGFR2
gene as model and succeeded in visualizing tissue-specific
expression profiles of the mutually exclusive exons through
differential expression of EGFP and RFP in mice for the first
time to our knowledge. Using the mostly entire genomic region
around alternative exons with their upper and lower constitutive
exons, we could evaluate which splice site sequences and cis-
elements are truly critical for regulations. This system has great
advantage, 1) to monitor the dynamism of splicing regulation in
vivo with single cell resolution, 2) to identify essential cis-elements
and trans-factors, and reveal the hidden mechanisms of splicing
regulation like this study, 3) to identify the essential candidate
factors by fluorescent color change or to screen the regulators
using cDNA or siRNA library. In this way, splicing reporter
system has great advantage to decipher the hidden splice code and
Figure 6. Foxs and ESRPs promote switching to exon 8 through repressing exon 9 via UGCAUG and ISE/ISS-3. (A) RT-PCR from HeLa
cell transfected the indicated wild-type or cis-mutated reporter vectors and Fox2 and/or ESRP1 expression vectors with or without Fox2 siRNA. The
bar graph shows the amount of each splicing product, and is based on calculations from three independent experiments; the mean value for each
splice product is show in the respective column, with an error bar showing the SD (standard error). (B) Result of an in vitro splice site recognition
assay. The scheme for exon 9 RNA probe shows the position of UGCAUG and ISE/ISS-3. The asterisk shows the probe crosslinked with U1, which binds
to the cryptic 5’ splice site inside exon 9.
doi:10.1371/journal.pone.0010946.g006
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PLoS ONE | www.plosone.org 9 June 2010 | Volume 5 | Issue 6 | e10946also to reveal the important roles regulated by alternative splicing
during development or in adult with tissue- or cell-type specific
manner.
With splicing reporter system, we showed that two mutually
exclusive exons of FGFR2 gene seem to have ‘‘primary’’ and
‘‘secondary’’ fates. Without tissue-specific regulators, ‘‘primary’’
Figure 7. Expression pattern of Foxs and ESRPs in splicing reporter mouse embryos. Sections from transgenic reporter embryos at E16.5.
EGFP signal showed the exon 8 splicing pattern, and in situ hybridization was performed with indicated probes using serial sections. The EGFP signal
is indicated by a white arrow. The violet signal, indicating mRNA localization, is shown by arrows, and nuclei were counterstained with Methyl Green
(scale bar=100 mm).
doi:10.1371/journal.pone.0010946.g007
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PLoS ONE | www.plosone.org 10 June 2010 | Volume 5 | Issue 6 | e10946exon 9 is chosen as the ‘‘default’’ and the ‘‘secondary’’ exon 8 is
silenced due to its weaker 3’ splice site with exonic and intronic
splice silencers sequence around exon 8 (Figure 8A, Non-Epithelial
or Mesenchymal regulation). When tissue-specific key regulator
ESRPs are expressed, these factors bind close to the 3’ splice site of
‘‘primary’’ exon 9 with Fox, repress exon 9 recognition, and then
‘‘secondary’’ exon 8 will be chosen instead of exon 9 (Figure 8A,
Epithelial regulation). In this step, exon 8 selection may be
activated by ESRPs and/or Foxs because ESRPs are cloned as
activators of 59 exon when its binding site is located in downstream
Figure 8. Model for tissue-specific splicing regulation of FGFR2 gene. (A) ‘‘The Knight’s Fork’’ regulation model: In non-epithelial or
mesenchymal tissues, exon 9 is chosen as ‘‘primary’’ exon due to its stronger 39 splice site than exon 8 (‘‘default’’ selection to choose ‘‘primary’’ exon).
In epithelial tissues, ‘‘key regulators’’ repress exon 9 utilizing its 39 splice site dependency for exon recognition and cause switch to ‘‘secondary’’ exons
(‘‘alternative’’ selection to choose ‘‘secondary’’ exon). A small number of ‘‘key regulators’’ can control two mutually exclusive exons through
modifying ordered splice-site recognitions in a tissue-specific manner, resembling the way that a chess piece can simultaneously attack a rook and
check the king. (B) In nematode, mutually exclusive splicing of the worm FGFR homologue gene of egl-15 is regulated by the cooperation of broadly
expressed Fox-1/ASD-1 family and the muscle-specific RNA binding motif protein (RBMs) of SUP-12 (a worm homologue of mRBM24), which act
together to repress inclusion of alternative exon 5B to promote muscle-specific expression of exon 5A. In the case of mammalian FGFR2, the Fox
family cooperates with the tissue-specific factor ESRPs (RBM35a and b) to repress alternative inclusion of exon 9 and to promote epithelial tissue-
specific expression of exon 8.
doi:10.1371/journal.pone.0010946.g008
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PLoS ONE | www.plosone.org 11 June 2010 | Volume 5 | Issue 6 | e10946intron [16,30,31]. Our observation that overexpression of ESRPs
mostly caused switching from exon 8 to exon 9, but did not
increase the double-skip form (Figure 5), may be in good
accordance with this hypothesis. However, in our X-link
experiment with RNA probe possessing both exon 8 and
UGCAUG+ISE/ISS-3 on its down-stream intron (intron 7,
77 bp; exon 8, 148 bp; intron 8,122 bp; UGCAUG+ISE/ISS-3
portion from 59 of exon 9, 165 bp), we could not observe the
increment of shifted band by addition of Fox2 and ESRP1 (data
not shown). The deleted elements (ISE2, ISAR, and so on) or
RNA structure may also be involved in the ESRPs-dependent
promotion of exon 8 recognition, although more clarification is
required.
Mutually exclusive alternative splicing regulated through the
ordered splicing recognition with tissue specific factors has been
observed in nematodes [33]. With this ordered splice-site
recognition, transacting regulators can sequentially control the
selection of mutually exclusive exons in a tissue-specific manner, in
a similar manner to which a chess piece, usually a knight, can
simultaneously attack a rook and check the king so that the former
must be lost (Figure 8A). This regulatory mechanism clearly
answered to our initial questions described in introduction. So far,
tissue-specific alternative splicing regulation has been understood
from the viewpoint of the balance between enhancement and
silencing of the alternative exons mediated by trans-factors
through specific cis-elements [3]. In this idea, each alternative
exon is regulated discretely, and the final splicing isoforms are
determined from the sum and balance of these independent
regulations. If this were the case in mutually exclusive alternative
splicing, the initial splicing products would be mixtures of the
single-exon-inclusion form, double-inclusion form, and double-
skip form. As the last two isoforms would be eliminated by NMD
[25], only the single-exon-inclusion forms would remain as final
splicing products. On the other hand, if mutually exclusive splicing
is regulated by the switch-like manner, the initial spliced products
would consist mainly of one of the single-inclusion forms. If the
exon selection in AT-3 cell is on a balance of combined regulations
of enhancer for exon 9 and repressor for exon 8, overexpression of
repressor for exon 9 should produce mostly the double-skip form.
We did not, however, observe this (Figure 5A). In addition, when
the 3’ slice site of exon 8 in the reporter was changed to be as
strong as that of exon 9, the double-inclusion splicing product
became dominant in AT-3 cell, without any change in the
transacting factors or specific cis-elements affecting exon 8
(Figure 2, lane 2). Also, splice site mutation of exon 9 caused
switching to epithelial exon 8 in non-epithelial AT-3 cell (Figure 3,
lane 2 and 4). These results suggest that alternative splicing is not
achieved by a complicated balance of multiple regulators, but is
defined by a simple switch-like mechanism in which only one
appropriate exon can be selected and switched by key regulators
such as ESRPs.
Our previous study showed that mutually exclusive splicing of
the worm FGFR homologue gene egl-15 is regulated by the
cooperation of broadly expressed Fox-1/ASD-1 family and the
muscle-specific RNA binding motif proteins (RBMs) of SUP-12 (a
nematode homologue of mRBM24), which act together to repress
inclusion of alternative exon 5B to promote muscle-specific
expression of exon 5A [34,35] (Figure 8B, nematode). In the case
of mammalian FGFR2, the generally expressed Fox family
cooperate with the tissue-specific factor ESRPs (RBM35a & b)
to repress alternative inclusion of exon 9 and to promote epithelial
tissue-specific expression of exon 8 (Figure 8B, mammals).
Moreover, both of nematode and mammalian Fox family proteins
bind to the UGCAUG element, and SUP-12 and ESRPs bind to
GU stretches. Nematode has rather similar number of genes
(,20,000) comparing with mammals but the size of its genome is
much smaller (about 1/30) with very shorter intron (average
561 bp). So, alternative splicing in nematode is considered to be
regulated with much simpler rules [36,37]. Thus, it is amazing that
regulatory mechanism of tissue-specific alternative splicing is
evolutionally conserved from nematode to mammal, and regula-
tion though Fox and another tissue-specific RBMs may turn out to
be a widespread essential phenomenon to regulate tissue-specific
alternative splicing of multiple genes. Our findings also provide the
significant cue to understand how a number of spliced genes are
regulated in various tissue-specific manners by a limited number of
regulators, eventually to understand seemingly complicated
developmental process or tissue-specific functions.
Materials and Methods
Plasmid construction
We constructed the reporter vector essentially as described in
the text. The FGFR2 genomic region spanning from exon 7 to
exon 10 from mouse genomic DNA was amplified by PCR and
cloned into Gateway Destination vector (Invitrogen), carrying both
EGFP (Clontech) and mRFP [38] with different reading frames,
under the control of the CAGGS promoter. To stabilize and
enhance reporter protein expression, artificial sequence of
modified glutathione S-transferase (GST) gene (QIAGEN) was
introduced in front of the FGFR2 genomic fragment and
connected in frame with exon 7. A 1-kbp fragment at the center
of the FGFR2 intron 9 was removed because of its significant
reducing effect in mRNA expression. Mutations of cis-elements
were introduced by using QuikChange XL II (Stratagene). Mouse
Fox1 and Fox2 cDNAs were kindly provided by Dr. Kawamoto
[39] and cloned into the Gateway Destination vector driven by a
CAGGS promoter. Primer sequences for amplifying FGFR2,
deleting 1 kbp in the middle of intron 9, and introducing
mutations were indicated in Methods S1.
Generation of FGFR2 splicing reporter mice
The constructed FGFR2 splicing reporter vector was linearized
and injected into the pronucleus of a C57BL/6 oocyte. Mice were
genotyped by PCR with primers for EGFP using genomic DNA
from the postnatal and late embryonic tails, or yolk sacs from
earlier embryos.
Ethics statement
All experiments involving animals were performed in accor-
dance with the protocols certified by the Institutional Animal Care
and Use Committee of the Tokyo Medical and Dental University
(Approval Numbers #0070220, #0080179, and #0090084).
Cell culture and transfection
Rat AT-3 and DT-3 prostate carcinoma cell lines were kindly
provided by Dr. Garcia-Blanco and Dr. Carstein. Cells were
maintained in Dulbecco’s modified eagle medium (D-MEM) with
10% fetal calf serum (FCS), and vectors were transfected with
TransFectin (BioRad). Stealth siRNA was used in knockdown
experiments on endogenous Fox2 and was transfected using
Lipofectamine RNAiMAX (Invitrogen).
Microscopy
Fluorescent images of whole embryos of reporter transgenic
mice were capture under a fluorescence microscope (MZ16FA,
Lecia) with a charge-coupled device (CCD) camera (DP71,
Olympus). We also used a confocal microscope (Fluoview
The Knight’s Fork Regulation
PLoS ONE | www.plosone.org 12 June 2010 | Volume 5 | Issue 6 | e10946FV1000, Olympus) to capture fluorescent images of sectioned
transgenic embryos, and the captured images were processed by
means of Metamorph (Molecular Devices). Fluorescent images of
cultured cells and bright-field images showing in situ hybridization
were captured by using a Nikon Eclipse E600 microscope with a
CCD camera (DP71, Olympus).
RT-PCR
Total RNAs and RT-PCR were performed as described
previously [34,40]. The identity of all splicing variants was
confirmed by sequencing. Amounts of PCR products were
measured with a 2100 BioAnalyzer with Agilent DNA1000 kits
(Agilent Technology), and the quantitative analyses were per-
formed in more than three independent experiments. Primer
sequences used in the RT-PCR assays are listed in Methods S2.
In vitro exon-recognition assay
The PCR products of T7-ex 9 wt (mouse FGFR2 intron 8,
200 nt; exon 9, 145 nt; and intron 9, 105 nt), T7-ex 9 containing
UGCAUG and ISE/ISS-3 in intron 8 (intron 8, 237 nt; exon 9,
145 nt; and intron 9, 74 nt), and T7-ex 8 wt (intron 8, 200 nt;
exon 8, 149 nt; and intron 9, 100 nt) were used as DNA templates
for T7 transcription. A mutated DNA template of 3’ ss in intron 8
and 5’ ss in intron 9 was prepared from mutated reporter vectors
as shown in Figure 3A. The RNA substrates were labeled with
32P
by in vitro T7 transcription. In vitro splicing reaction and UV
cross linking were performed under the conditions described by
Sawa [29]. To identify the shifted bands by UV cross linking, pre-
heated cDNA oligo (10 mg/mL) for U1 (5’-CGGAGTGCAATG-
3’) or U2 (5’-CAGATACTACACTTG-3’) was added to the
RNAs after UV cross linking, and the U1 or U2 cDNA oligo/
RNAs mixture were digested with 50 U/mL of RNase H at 30uC
for 10 min. In Figure 6A, highly purified Flag-Fox2 and Flag-
ESRP1 were added to RNAs and incubated at room temperature
for 5 min before splicing reaction to examine their inhibitory or
activating effects on exon recognition of U1 snRNA or U2
snRNA. After these reactions, RNAs were subjected to denaturing
PAGE analysis and autoradiography.
In situ hybridization
In situ hybridization was carried out as previously described
[41,42], with modifications. Briefly, embryos were fixed with 4%
paraformaldehyde, cryo-protected with 30% sucrose, embedded in
optimal cutting temperature (OCT) compound, and cut into
sections in 20 mm thickness. Antisense RNA probes labeled with
digoxigenin were visualized with Fab fragments from an antibody
against digoxigenein conjugated with alkaline phosphatase (Roche)
and 5-bromo-4-chloro-3-indolyl phosphate (BCIP)/Nitroblue Tet-
razolium (NBT) solutions. Sections were counterstained with
Methyl Green. The following cDNA was used as the riboprobe:
Fox1 (131–865 bp from mouse cDNA), Fox2 (2261–2991 bp from
mouse cDNA), ESRP1 (1168–1708 bp from mouse cDNA), and
ESRP2 (208–807 bp from mouse cDNA).
Supporting Information
Figure S1 In vitro splice site recognition assay of exon 9 RNA
probe with snRNA oligos ‘‘X-link’’ shows the presence or absence
of UV-induced crosslinks in samples after the in vitro splicing
reaction. U1, U2, U2(2), U2(3), U1+U2, or U6 oligos represent the
digestion of RNA samples by RNaseH with complementary oligos,
respectively. U2 complementary oligos of U2(2) and U2(3), which
target different portion of U2 snRNA, were used to compare the
digestion efficiency. Shifted band almost disappeared with double
digestion using U1+U2 oligos (lane 7), while the band was resistant
against the digestion with U6 oligo (lane8), indicating that the exon
9 RNA probe is recognized by U1 and U2 snRNA. The band
shown by arrowheads with asterisk may be a probe crosslinked
with U1 that binds to the cryptic 5’ splice site inside exon 9, as
already described in the figure legend of Fig-3C. Sequence of
U2(2) and U2(3) oligos U2: same oligo used in Fig-3 U2(2):
cagtttaatatctg U2(3): ccatttaatatatt U6: cgcttcacgaatttgcgt.
Found at: doi:10.1371/journal.pone.0010946.s001 (5.24 MB TIF)
Methods S1 Primer sequences for amplifying FGFR2, deleting
1 kbp in the middle of intron 9, and introducing mutations.
Found at: doi:10.1371/journal.pone.0010946.s002 (0.02 MB
DOC)
Methods S2 Primer sequences used in the RT-PCR assays.
Found at: doi:10.1371/journal.pone.0010946.s003 (0.02 MB
DOC)
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